By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Despite the sluggish economy and an overall flat funding picture, the life science market will continue "to provide investors with attractive risk/reward opportunities" over the next several years, with the molecular diagnostics space one of the most attractive markets, according to an analyst report issued last night.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.